Ubs Ag London Branch Autocallable Contingent Interest Barrier N (ABKTZXX)

it's been two years and the taran who was the only bidder for the assets. got it for free. and the creditor claims were all fake. in this bankruptcy fraud case. that is all you need to know. the question is whether the molecule lenzilumab has any value. or IP value that a big pharma would want to o

Ask them why they're letting HIRU burn down

My error Goats. Meant to write Boynton and Bosch.

Read this very carefully!

Who owns the patents to Lym-x-Sorb?

The original foundational patents and core intellectual property rights for the Lym-X-Sorb® technology platform are owned by BioMolecular Products, Inc., the Massachusetts-based biotechnology firm founded b

Entertaining some numbers that was thrown out there.....when im unsure about something I dont post it on other boards...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177768696

We dont know if these ae=re the same style belts or nothing, Very little info which

🌶️ once you click the link, see below the PINK Triangle, click the yellow hourglass, it will display the definition, which applies to WHENs status... (sorry for the difficulty)

The excerpt was directly from this OTC markets site/ WHEN

I actually had to p

I was expecting a little more with my Reitan pick. He will probably need to go 3 or 4 under today. I'll try to get up at 6 am to catch the afternoon squad.

Ubiquitous you are telling us 👍️

what was this lawsuit about?t

Last one .. and good night!
The developmental and clinical phase status of products utilizing the Lym-X-Sorb® technology platform varies significantly by application. The platform spans fully approved, commercially available medical foods to active, clinical-stage oncology treatments.1. Medi

Adam Rozencwajg (Goehring & Rozencwajg): $70 Oil: Setting Up the Next Bull Market

https://youtu.be/DczYUdpbTAs

It certainly is a good morning at MCIC. I promise you that. https://investorshub.advfn.com/uimage/uploads/2026/7/10/gonhj1516489136686.jpeg

Fills a couple gaps ? Are u joking ? CEO is stealing the gaps..
Everyday

Everyday...up .10 then down .20......CEO just sits there and does nothing.... 

Thats true IMO Ron. 75/25 happened because SNH were caught red handed, they had to share the pie but, they played again the regular game they play. Thats gone. They can't share something which never existed "Equity" in CH11, I have all three flavors either way is fine with me. It is estates responsi

Be f u c k I n g over joyed with $5. F u c k I n g pos CEO.

Wow all these folks getting in where they fit in. Good to see. This seems to be a jewel.Been in for a couple months  watching n loading quietly 
This should be good in the next few months we could 1$

If you’re going to spread gloom & doom rumors, learning to spell ‘conversion’ would be a good start.

I think we have a winner here!
Clinical trials for Lym-X-Sorb® have targeted two primary medical applications: gastrointestinal nutrition (Cystic Fibrosis) and oncology drug delivery (Cancer).Because the lipid matrix behaves like an easily absorbed micelle, it bypasses traditional digestive

Zapata Quantum Inc. (OTCQB: ZPTA): Virtual Investor Conferences

https://youtu.be/dRcqyzYFxoo

Weekly Chart
https://schrts.co/ImdWxUFY

Good luck, and i see i'm yet again in a decent position day 1,
hopefully not to repeat a day 2-3-4 crash as per usual lately. GL

Anyway, my DK entry for this week, playing a $10 double-up. I might be lose one player, but 2 is very difficult.

https://i.postimg.cc/NGJzcMgt/DK-260709-1.jpg

Dotz Nano Ltd. (OTCQB: DTZNY | ASX: DTZ): Virtual Investor Conferences

https://youtu.be/NLwN23CK950

Dont we know this?